Income Tax Expense (Benefit) of Perspective Therapeutics, Inc. from 30 Jun 2014 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Perspective Therapeutics, Inc. annual and quarterly Income Tax Expense (Benefit) in USD history and change rate from 30 Jun 2014 to 31 Dec 2024.
  • Perspective Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Dec 2023 was $7,849,000.
  • Perspective Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending 31 Dec 2023 was $2,651,000.
  • Perspective Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was $2,097,000, a 21% increase from 2023.
  • Perspective Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $2,651,000.
  • Perspective Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)

Perspective Therapeutics, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,097,000 +$554,000 +21% 01 Jan 2024 31 Dec 2024 10-K/A 28 Mar 2025 2024 FY
2023 $2,651,000 -$2,651,000 01 Jan 2023 31 Dec 2023 10-K/A 28 Mar 2025 2024 FY
2022 $0 $0 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $0 $0 01 Jul 2020 30 Jun 2021 10-KT 01 May 2023 2023 Q1
2020 $0 $0 01 Jul 2019 30 Jun 2020 10-KT 01 May 2023 2023 Q1
2019 $0 $0 01 Jul 2018 30 Jun 2019 10-K 27 Sep 2021 2021 FY
2018 $0 $0 01 Jul 2017 30 Jun 2018 10-K 25 Sep 2020 2020 FY
2017 $0 $0 01 Jul 2016 30 Jun 2017 10-K 27 Sep 2019 2019 FY
2016 $0 $0 01 Jul 2015 30 Jun 2016 10-K 26 Sep 2018 2018 FY
2015 $0 $0 01 Jul 2014 30 Jun 2015 10-K 28 Sep 2017 2017 FY
2014 $0 01 Jul 2013 30 Jun 2014 10-K 09 Sep 2016 2016 FY

Perspective Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2023 $2,651,000 $7,849,000 +$7,849,000 01 Oct 2023 31 Dec 2023 10-K/A 28 Mar 2025 2024 FY
Q3 2023 $10,500,000 $0 $0 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $10,500,000 $0 $0 01 Apr 2023 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $10,500,000 $10,500,000 -$10,500,000 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $0 $0 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $0 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $0 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $0 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.